UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Partial Adenosine A1 Agonist in Heart Failure

Handbook of experimental pharmacology, 2017, Vol.243, p.177-203

2017

Volltextzugriff (PDF)

Dasatinib

Recent results in cancer research, 2010, Vol.184, p.83

2010

Volltextzugriff (PDF)

Compound immobilization and drug-affinity chromatography

Methods in molecular biology (Clifton, N.J.), 2012, Vol.803, p.25

2012

Volltextzugriff (PDF)

Antibacterial drug discovery and development--SRI's 11th Annual Summit

IDrugs : the investigational drugs journal, 2006, Vol.9 (6), p.390

Hawser, Stephen P

2006

Volltextzugriff (PDF)

Diabetology between genetics and pharmacology; report from the 36th annual meeting of the German Diabetes Association, May 23-26, 2001 at Aachen

Der Internist, 2001, Vol.42 (10), p.1428-1431

Stiefelhagen, P

2001

Volltextzugriff (PDF)

Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide

Journal - Oklahoma State Medical Association, 2007-07, Vol.100 (7), p.267

2007

Volltextzugriff (PDF)

Cox 2: the next stage in the NSAID story

Practitioner, 1996-09, Vol.240 (1566), p.532

Averns, H

1996

Volltextzugriff (PDF)

Insulin analogs and new oral antidiabetic drugs

Duodecim (Helsinki, Finland : 1961), 1999, Vol.115 (20), p.2197

Koivisto, V

1999

Volltextzugriff (PDF)

General Cytotoxicity Assessment by Means of the MTT Assay

Methods in molecular biology (Clifton, N.J.), 2015, Vol.1250, p.333

2015

Volltextzugriff (PDF)

New and Emerging Therapies and Targets: Beta-3 Agonists

Handbook of experimental pharmacology, 2017, Vol.243, p.205-223

2017

Volltextzugriff (PDF)

Anticoagulation Therapy and NOACs in Heart Failure

Handbook of experimental pharmacology, 2017, Vol.243, p.515-535

2017

Volltextzugriff (PDF)

Determination of Cytotoxicity

Pharmacological Assays of Plant-Based Natural Products, 2016, Vol.71, p.159-161

Parimelazhagan, Thangaraj

2016

Volltextzugriff (PDF)

Thrombin enhances glioma growth

Acta neurochirurgica. Supplement, 2008, Vol.102, p.363

2008

Volltextzugriff (PDF)

American Chemical Society--234th National Meeting. Syntheses of novel compounds and data on novel therapeutics. 19-23 August 2007, Boston, MA, USA

IDrugs : the investigational drugs journal, 2007, Vol.10 (10), p.681

Rotella, David

2007

Volltextzugriff (PDF)

From the COX-concept (Cyclooxygenase-2) to clinical gain. Meloxicam sets the standard. World-wide interactive video conference, London, 26 September 1997

Zeitschrift fur Orthopadie und ihre Grenzgebiete, 1997, Vol.135 (6 Suppl), p.1-4

1997

Volltextzugriff (PDF)

New development in diabetes therapy. 35th Annual Meeting of the German Diabetes Society, Munich, May 5-June 3, 2000

Der Internist (Berlin), 2000, Vol.41 (9), p.930

Stiefelhagen, P

2000

Volltextzugriff (PDF)

Drug watch

Positively aware, 1999-03, Vol.10 (2), p.14

Whitson, S

1999

Volltextzugriff (PDF)

1 – 17 von 17

Menü

Weitere Dienste

Einstellungen

Partial Adenosine A1 Agonist in Heart Failure

Dasatinib

Compound immobilization and drug-affinity chromatography

Antibacterial drug discovery and development--SRI's 11th Annual Summit

Diabetology between genetics and pharmacology; report from the 36th annual meeting of the German Diabetes Association, May 23-26, 2001 at Aachen

Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide

Cox 2: the next stage in the NSAID story

Insulin analogs and new oral antidiabetic drugs

General Cytotoxicity Assessment by Means of the MTT Assay

New and Emerging Therapies and Targets: Beta-3 Agonists

Anticoagulation Therapy and NOACs in Heart Failure

Determination of Cytotoxicity

Thrombin enhances glioma growth

American Chemical Society--234th National Meeting. Syntheses of novel compounds and data on novel therapeutics. 19-23 August 2007, Boston, MA, USA

From the COX-concept (Cyclooxygenase-2) to clinical gain. Meloxicam sets the standard. World-wide interactive video conference, London, 26 September 1997

New development in diabetes therapy. 35th Annual Meeting of the German Diabetes Society, Munich, May 5-June 3, 2000

Drug watch

Aktive Filter

Suchergebnisse filtern